902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I

Healthcare resource utilization with prophylactic intravenous anakinra following anti CD19 CAR T therapy in B cell lymphoma A Canadian single center quality improvement experience

Oncodif An auditable AI framework for automated genomic curation and natural language clinical querying in hematologic malignancies

Impact of protein energy malnutrition on in hospital outcomes in patients undergoing bone marrow transplantation Insights from a national inpatient sample

Creating a tool for measuring preferences for treating blood cancers in older adults using implementation science

Building a kenyan framework for advanced multiple myeloma care Outcomes from the 2024 national workshop

Accelerating practical solutions for bispecific antibody consideration for multiple myeloma in the community setting Findings from an implementation science initiative

Evaluating the impact of language on health care utilization outcomes in paitents with diffuse large B cell lymphoma at a large safety net hospital

Optimizing multiple myeloma assessment for newly diagnosed patients across a large 33 hospital healthcare system A mixed methods analysis

Economic burden of relapse in patients with acute lymphoblastic leukemia A retrospective claims based analysis

Treatment setting matters Academic cancer centers deliver superior survival in MALT lymphoma –  an NCDB analysis of 77 000 patients

Cost conscious CAR T delivery Outpatient OP cilta cel administration reduces health care resource utilization HCRU and the associated post infusion cost

A population based gap analysis of bispecific antibody trial access Racial geographic and Medicaid linked disparities in lymphoma and myeloma

Factors associated with remote healthcare utilization in MM patients undergoing autologous stem cell transplantation

Factors influencing patient treatment selection among bispecific antibodies for relapsed refractory multiple myeloma RRMM A mixed methods study

Differences in insurer payments for hematology part B drugs between traditional Medicare and Medicare advantage

A national lens on follicular lymphoma Academic care linked to improved survival in 158 000 patients

Budget impact of fixed duration acalabrutinib in combination with venetoclax in previously untreated chronic lymphocytic leukemia patients in the United States

Trends in triplet and quadruplet regimen utilization among patients with newly diagnosed multiple myeloma during 2017 2024

Advancing adoption of evidence based quadruplet treatment regimens for newly diagnosed multiple myeloma in community practice Insights from a quality improvement initiative

Optimizing adherence to oral CLL therapies in community oncology centers Key findings from a quality improvement initiative

Inequity in travel burden among patients receiving bispecific antibodies BsAbs for diffuse large B cell lymphoma DLBCL and follicular lymphoma FL A real world study of Medicare beneficiaries in the United States US